Bio Essence (BIOE) Share-based Compensation (2020)

Bio Essence (BIOE) recorded quarterly Share-based Compensation of $3958.0 in Q2 2020, down 19.75% quarter-over-quarter from $4932.0 in Q1 2020.

Bio Essence (BIOE) Share-based Compensation (2020) Analysis & Trends

Bio Essence's Share-based Compensation history runs 1 years deep, the most recent figure standing at $3958.0 for Q2 2020.

In Q2 2020, Share-based Compensation changed N/A year-over-year to $3958.0; the TTM figure through Dec 2020 stood at $8890.0 (changed N/A YoY), while the FY2020 annual figure was $8890.0, changed N/A from the prior year.
Share-based Compensation was $3958.0 for Q2 2020 at Bio Essence, down from $4932.0 in the prior quarter.
In the past five years, Share-based Compensation ranged from a high of $4932.0 in Q1 2020 to a low of $3958.0 in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Stock Comp. (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	43.00 Mn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	25.00 Mn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	33.90 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	-395,114.54
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	57.20 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	21.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	36.33 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	16.04 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	36.86 Mn
10	Bio Essence	-	-	319,353.00	-

Download Data